company background image
002923 logo

Zhuhai Rundu Pharmaceutical SZSE:002923 Stock Report

Last Price

CN¥9.95

Market Cap

CN¥3.3b

7D

0.7%

1Y

-28.1%

Updated

26 Nov, 2024

Data

Company Financials

Zhuhai Rundu Pharmaceutical Co., Ltd.

SZSE:002923 Stock Report

Market Cap: CN¥3.3b

002923 Stock Overview

Develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, and CNS worldwide. More details

002923 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends2/6

Zhuhai Rundu Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhuhai Rundu Pharmaceutical
Historical stock prices
Current Share PriceCN¥9.95
52 Week HighCN¥13.84
52 Week LowCN¥6.81
Beta0.36
11 Month Change3.00%
3 Month Change16.10%
1 Year Change-28.06%
33 Year Change-47.19%
5 Year Change11.30%
Change since IPO33.10%

Recent News & Updates

Zhuhai Rundu Pharmaceutical's (SZSE:002923) Shareholders Have More To Worry About Than Only Soft Earnings

Nov 04
Zhuhai Rundu Pharmaceutical's (SZSE:002923) Shareholders Have More To Worry About Than Only Soft Earnings

Zhuhai Rundu Pharmaceutical's (SZSE:002923) Dividend Is Being Reduced To CN¥0.20

May 29
Zhuhai Rundu Pharmaceutical's (SZSE:002923) Dividend Is Being Reduced To CN¥0.20

Recent updates

Zhuhai Rundu Pharmaceutical's (SZSE:002923) Shareholders Have More To Worry About Than Only Soft Earnings

Nov 04
Zhuhai Rundu Pharmaceutical's (SZSE:002923) Shareholders Have More To Worry About Than Only Soft Earnings

Zhuhai Rundu Pharmaceutical's (SZSE:002923) Dividend Is Being Reduced To CN¥0.20

May 29
Zhuhai Rundu Pharmaceutical's (SZSE:002923) Dividend Is Being Reduced To CN¥0.20

There May Be Reason For Hope In Zhuhai Rundu Pharmaceutical's (SZSE:002923) Disappointing Earnings

May 05
There May Be Reason For Hope In Zhuhai Rundu Pharmaceutical's (SZSE:002923) Disappointing Earnings

There's Reason For Concern Over Zhuhai Rundu Pharmaceutical Co., Ltd.'s (SZSE:002923) Massive 32% Price Jump

Mar 05
There's Reason For Concern Over Zhuhai Rundu Pharmaceutical Co., Ltd.'s (SZSE:002923) Massive 32% Price Jump

Shareholder Returns

002923CN PharmaceuticalsCN Market
7D0.7%0.3%-0.6%
1Y-28.1%-7.9%3.2%

Return vs Industry: 002923 underperformed the CN Pharmaceuticals industry which returned -7.9% over the past year.

Return vs Market: 002923 underperformed the CN Market which returned 3.2% over the past year.

Price Volatility

Is 002923's price volatile compared to industry and market?
002923 volatility
002923 Average Weekly Movement5.9%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 002923 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002923's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19971,945Jie Liuwww.rdpharma.cn

Zhuhai Rundu Pharmaceutical Co., Ltd. develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, and CNS worldwide. It offers APIs, intermediates, FDF, and pellets. The company was founded in 1997 and is headquartered in Zhuhai, China.

Zhuhai Rundu Pharmaceutical Co., Ltd. Fundamentals Summary

How do Zhuhai Rundu Pharmaceutical's earnings and revenue compare to its market cap?
002923 fundamental statistics
Market capCN¥3.33b
Earnings (TTM)CN¥38.52m
Revenue (TTM)CN¥1.22b

86.5x

P/E Ratio

2.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002923 income statement (TTM)
RevenueCN¥1.22b
Cost of RevenueCN¥691.14m
Gross ProfitCN¥532.37m
Other ExpensesCN¥493.85m
EarningsCN¥38.52m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.12
Gross Margin43.51%
Net Profit Margin3.15%
Debt/Equity Ratio43.9%

How did 002923 perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

176%

Payout Ratio